Medovex Corporation Enters Into International Distribution Agreement for Spain With PRIM Group

Medovex Corp.

, a developer of medical technology products, today announced that the Company has entered into an international distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its DenerveX(TM) System throughout Spain using PRIM's Orthopedic Division. Dennis Moon, Medovex Executive Vice President, stated, "PRIM Group in Spain serves as a perfect call point fit for our mission to provide a successful distribution, sales and marketing foundation for our entry of the DenerveX System in an important market in Europe." "With PRIM Group as our distributor in Spain, we are closing a gap and show professional presence in a major market in Europe," added Manfred Sablowski, Senior Vice President Sales & Marketing. "Our goal is to continuously improve our market presence throughout Europe by expanding our network of strong distributors with knowledgeable sales and support personnel, and in close proximity to our customers." PRIM Group is expected to provide sales, marketing and distribution services throughout Spain for the launch of the DenerveX System. The DenerveX System is designed to provide relief of pain associated with the facet joint. Lower back pain is the second most common cause of disability in the U.S. for adults. Studies indicate that 10% of the U.S. adult population suffers from lower back pain and that 31% of lower back pain is attributed to facet joint pain. The DenerveX System consists of the DenerveX device, a single use device, and the DenerveX Pro-40 Power Generator. The DenerveX system is designed to provide a minimally invasive treatment option which combines two actions into one device. The combined procedure is expected to provide a longer lasting solution and potential savings to the health care system. The Company's patented DenerveX System is currently in development and not yet FDA cleared, CE marked or commercially available.